Intravesical instillation of bacillus Calmette-Guérin (BCG) is the adjuvant therapy for
superficial urothelial carcinoma of the bladder with the lowest recurrence rates and is well …

Abstract Bacillus Calmette-Guérin (BCG) is the most effective intravesical immunotherapy for
superficial bladder cancer. Although generally well tolerated, BCG-related infectious …

Local immunotherapy with bacillus Calmette-Guerin (BCG) is an effective and frequently
used treatment for superficial bladder cancer. Serious side effects are infrequent but can …

Intravesical instillation of the bacillus Calmentte-Gu rin (BCG), an attenuated strain of
Mycobacterium bovis, is an approved method for the treatment of superficial bladder cancer …

A 76‐year‐old man received intravesical bacillus Calmette‐Guérin (BCG) instillations for
recurrent superficial bladder cancer. He had undergone right nephroureterectomy for right …

Abstract Intravesical bacillus Calmette Guérin (BCG) instillation has been used as
immunotherapy for early stage bladder cancer for> 40 years. Complications from this …

Abstract Background: Intravesical bacillus Calmette-Guerin (BCG) therapy is an effective
and widely used treatment for superficial bladder carcinoma. Local complications are …

Background: Intravesical bacillus Calmette–Guerin (BCG) is widely used in the management
of bladder cancer but because it is a living organism, local and disseminated infection may …

Abstract Intravesical bacillus Calmette-Guerin (BCG) instillation has been adopted for the
treatment of patients with superficial bladder cancer. Severe adverse events due to local …

DISCUSSION: BCG is derived from an attenuated strain of virulent Mycobacterium bovis that
can cause disease in humans. Hypersensitivity pneumonitis to BCG treatments has been …